advertisement
DataPulse: Key Clinical Trial Insights in Non-Muscle Invasive Bladder Cancer (NMIBC) From AUA 2025
Explore the latest findings in NMIBC presented at AUA 2025 in Las Vegas through concise video briefs and expert perspectives to better understand trial data and their potential impact on clinical practice.
Episodes 1-4 of 4
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
CME/CEExpert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
SunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results
Oncology and HematologySunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results
First Results From Cohort 4 of the SunRISe-1 Trial
Oncology and HematologyFirst Results From Cohort 4 of the SunRISe-1 Trial
Trial in Progress: Phase 3 MoonRISe-3 Study
Oncology and HematologyTrial in Progress: Phase 3 MoonRISe-3 Study
- advertisement
